Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Sep;78(9):702–706. doi: 10.1136/bjo.78.9.702

Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases.

C L Shields 1, J A Shields 1, P De Potter 1, A D Singh 1
PMCID: PMC504910  PMID: 7947552

Abstract

The coral derived hydroxyapatite sphere is a popular, integrated orbital implant designed to provide improved motility of the ocular prosthesis following enucleation. Although the implant has rapidly become widely used by ophthalmologists, little information is available regarding the problems of this technique in a large series of cases. Experience with 250 consecutive cases of hydroxyapatite orbital implant use was reviewed and the problems of the implants and their management investigated specifically. The reasons for enucleation included uveal melanoma (157 cases), retinoblastoma (70 cases), blind painful eye (22 cases), and intraocular medulloepithelioma (one case). Earlier treatment to the eye was performed before enucleation in 47 cases and included repair of ruptured globe (17 cases), plaque radiotherapy (18 cases), external beam radiotherapy (six cases), and others (six cases). During a mean of 23 months' follow up (range 6-40 months), there have been no recognisable cases of orbital haemorrhage related to the implant, and no cases of implant extrusion or implant migration. There was one case of presumed orbital infection (culture negative) that resolved with intravenous antibiotics and the implant was retained within the orbit. Other problems included conjunctival thinning in eight cases managed by observation and prosthesis adjustment, and conjunctival erosion in four cases managed by combinations of scleral patch graft, conjunctival flap, and prosthesis adjustment. The conjunctival erosion was caused by a poorly fitting prosthesis in three cases and wound dehiscence in one case. The problem rate in eyes receiving prior radiotherapy or surgery was not increased. The hydroxyapatite integrated orbital implant is a well tolerated motility implant without the high rate of extrusion and infection seen with other motility implants. The prosthesis fit may contribute to the tolerance of the implant.

Full text

PDF
702

Images in this article

704Image
on p.704
704Image
on p.704
705Image
on p.705
705Image
on p.705

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benevento W. J., Murray P., Reed C. A., Pepose J. S. The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine. Am J Ophthalmol. 1990 Mar 15;109(3):329–333. doi: 10.1016/s0002-9394(14)74560-x. [DOI] [PubMed] [Google Scholar]
  2. Buettner H., Bartley G. B. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol. 1992 Jun 15;113(6):669–673. doi: 10.1016/s0002-9394(14)74792-0. [DOI] [PubMed] [Google Scholar]
  3. De Potter P., Shields C. L., Shields J. A., Flanders A. E., Rao V. M. Role of magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant. Ophthalmology. 1992 May;99(5):824–830. doi: 10.1016/s0161-6420(92)31918-9. [DOI] [PubMed] [Google Scholar]
  4. De Potter P., Shields C. L., Shields J. A., Singh A. D. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol. 1994 Feb;112(2):208–212. doi: 10.1001/archopht.1994.01090140084028. [DOI] [PubMed] [Google Scholar]
  5. De Potter P., Shields J. A., Shields C. L., Santos R. Modified enucleation via lateral orbitotomy for choroidal melanoma with orbital extension: a report of two cases. Ophthal Plast Reconstr Surg. 1992;8(2):109–113. doi: 10.1097/00002341-199206000-00004. [DOI] [PubMed] [Google Scholar]
  6. Dutton J. J. Coralline hydroxyapatite as an ocular implant. Ophthalmology. 1991 Mar;98(3):370–377. doi: 10.1016/s0161-6420(91)32304-2. [DOI] [PubMed] [Google Scholar]
  7. Goldberg R. A., Holds J. B., Ebrahimpour J. Exposed hydroxyapatite orbital implants. Report of six cases. Ophthalmology. 1992 May;99(5):831–836. doi: 10.1016/s0161-6420(92)31920-7. [DOI] [PubMed] [Google Scholar]
  8. Harbison M. A., Hammer S. M. Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine. J Acquir Immune Defic Syndr. 1989;2(1):16–20. [PubMed] [Google Scholar]
  9. Holmes R. E. Bone regeneration within a coralline hydroxyapatite implant. Plast Reconstr Surg. 1979 May;63(5):626–633. doi: 10.1097/00006534-197905000-00004. [DOI] [PubMed] [Google Scholar]
  10. Kenney E. B., Lekovic V., Sa Ferreira J. C., Han T., Dimitrijevic B., Carranza F. A., Jr Bone formation within porous hydroxylapatite implants in human periodontal defects. J Periodontol. 1986 Feb;57(2):76–83. doi: 10.1902/jop.1986.57.2.76. [DOI] [PubMed] [Google Scholar]
  11. Merriam J. C., Rosskothen H. D., Benedek E. Right-angled peg for hydroxyapatite orbital implant. Ophthalmic Surg. 1992 Aug;23(8):564–564. [PubMed] [Google Scholar]
  12. Piecuch J. F. Extraskeletal implantation of a porous hydroxyapatite ceramic. J Dent Res. 1982 Dec;61(12):1458–1460. doi: 10.1177/00220345820610121801. [DOI] [PubMed] [Google Scholar]
  13. Piecuch J. F., Topazian R. G., Skoly S., Wolfe S. Experimental ridge augmentation with porous hydroxyapatite implants. J Dent Res. 1983 Feb;62(2):148–154. doi: 10.1177/00220345830620021301. [DOI] [PubMed] [Google Scholar]
  14. Regillo C. D., Shields C. L., Shields J. A., Eagle R. C., Jr, Lehr J. Ocular tuberculosis. JAMA. 1991 Sep 18;266(11):1490–1490. [PubMed] [Google Scholar]
  15. Rosen H. M. Surgical correction of the vertically deficient chin. Plast Reconstr Surg. 1988 Aug;82(2):247–256. doi: 10.1097/00006534-198808000-00006. [DOI] [PubMed] [Google Scholar]
  16. Sartoris D. J., Gershuni D. H., Akeson W. H., Holmes R. E., Resnick D. Coralline hydroxyapatite bone graft substitutes: preliminary report of radiographic evaluation. Radiology. 1986 Apr;159(1):133–137. doi: 10.1148/radiology.159.1.3513246. [DOI] [PubMed] [Google Scholar]
  17. Shields C. L., Shields J. A., De Potter P. Hydroxyapatite orbital implant after enucleation. Experience with initial 100 consecutive cases. Arch Ophthalmol. 1992 Mar;110(3):333–338. doi: 10.1001/archopht.1992.01080150031022. [DOI] [PubMed] [Google Scholar]
  18. Shields C. L., Shields J. A., Eagle R. C., Jr, De Potter P. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. Am J Ophthalmol. 1991 Mar 15;111(3):363–366. doi: 10.1016/s0002-9394(14)72323-2. [DOI] [PubMed] [Google Scholar]
  19. Shields J. A., Shields C. L., De Potter P. Enucleation technique for children with retinoblastoma. J Pediatr Ophthalmol Strabismus. 1992 Jul-Aug;29(4):213–215. doi: 10.3928/0191-3913-19920701-06. [DOI] [PubMed] [Google Scholar]
  20. Soll D. B. The anophthalmic socket. Ophthalmology. 1982 May;89(5):407–423. doi: 10.1016/s0161-6420(82)34774-0. [DOI] [PubMed] [Google Scholar]
  21. White E., Shors E. C. Biomaterial aspects of Interpore-200 porous hydroxyapatite. Dent Clin North Am. 1986 Jan;30(1):49–67. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES